SCHEMBL2746474

SCHEMBL2746474

COC(=O)c1cc(-c2ncco2)cc(-c2cnc(N)nc2N)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLRA3 O75311 1/20 0.57
▸ GLRB P48167 1/20 0.57
▸ CFTR P13569 1/20 0.43
▸ DHFR P00374 5/20 0.39
▸ ROCK1 Q13464 2/20 0.38
▸ FGFR1 P11362 2/20 0.36
▸ LCK P06239 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ATAD2 Q6PL18 1/20 0.34
▸ PDGFRB P09619 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27631885 0.81 ATAD2 (0.48) DHFRROCK1FGFR1ATAD2PDGFRB
SCHEMBL475724 0.80 GLRA3 (0.77) GLRA3GLRBCFTRATAD2MAPT
SCHEMBL2527622 0.80 GLRA3 (0.68) GLRA3GLRBCFTRROCK1ADORA2A
SCHEMBL475508 0.76 GLRA3 (0.70) GLRA3GLRBCFTRKDM4EALDH1A1
SCHEMBL29430430 0.75 ADORA2A (0.41) CFTRDHFRLCKKITADORA2A
SCHEMBL4479622 0.75 ADORA2A (0.41) CFTRDHFRLCKKITADORA2A
SCHEMBL29430444 0.74 DHFR (0.57) DHFRFGFR1ADORA2A
SCHEMBL4468439 0.74 DHFR (0.57) DHFRFGFR1ADORA2A
SCHEMBL29430388 0.74 DHFR (0.49) DHFRLCKKITADORA2A
SCHEMBL4472861 0.74 DHFR (0.49) DHFRLCKKITADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178671-B2 Ring attached at N2 and N4 of 2,4-pyrimidinediamines; for treating rheumatoid arthritis; N4-(2,2-dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine RIGEL PHARMACEUTICALS, INC. (US) 2012-05-15 — — US disclosed
Send feedback